Most importantly, the anti‐MMR Nb‐IMDQ conjugate led to efficient drug delivery to the MMRhigh TAMs in vivo, causing a significant decline in tumor growth, paralleled by a repolarization of TAMs towards a pro‐inflammatory phenotype and an increase in anti‐tumor T cell responses. This evidence concerns the gene MRC1 and neoplasm.